RUA Life Sciences is a holding company for a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM).

11 Aug 2020

RUA Life Sciences - AGM Statement - Management update - August 2020

Chairman, Bill Brown and CEO, David Richmond discuss a year of substantial change and progress for RUA and update on both the Group's prospects and an encouraging recent recovery in orders after the initial impact of the pandemic.

Return to RUA Life Sciences

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 2nd Floor, Park House, 16-18 Finsbury Circus, London, EC2M 7EB

Website design & development by Breckenridge